Alicia Grande is CFO & VP +1 at CATALYST PHARMACEUTICALS, INC. (CPRX). They have made 15 open-market trades across 1 company since 2008, most recently 2023-12-27.
CIK 0001402652
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $33K since 2008, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPRX | 59,223 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2023-12-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | SELL | 2023-12-08 | 2023-12-12 | $13.97 | $1.4M | +24.7% | +10.6% | +21.1% |
| CPRX | SELL | 2023-03-28 | 2023-03-30 | $16.62 | $2.4M | +6.1% | +2.4% | -19.3% |
| CPRX | SELL | 2023-03-22 | 2023-03-24 | $16.50 | $1.4M | +4.4% | +1.8% | -19.1% |
| CPRX | SELL | 2022-11-22 | 2022-11-23 | $16.53 | $4.0M | -2.8% | +12.3% | -9.9% |
| CPRX | SELL | 2022-11-15 | 2022-11-17 | $15.77 | $946K | +8.2% | +5.9% | -0.9% |
| CPRX | SELL | 2022-09-23 | 2022-09-26 | $11.90 | $714K | +1.5% | +16.2% | +51.3% |
| CPRX | SELL | 2022-09-16 | 2022-09-20 | $13.50 | $1.2M | +0.1% | -0.5% | +28.0% |
| CPRX | SELL | 2022-09-14 | 2022-09-16 | $15.57 | $779K | -2.0% | +0.4% | +29.4% |
| CPRX | SELL | 2022-08-26 | 2022-08-30 | $14.23 | $969K | +9.5% | -8.2% | +19.1% |
| CPRX | SELL | 2022-08-17 | 2022-08-19 | $13.83 | $4.2M | -2.9% | -7.0% | +9.7% |
| CPRX | SELL | 2021-08-17 | 2021-08-19 | $5.67 | $641K | +1.7% | -10.5% | +37.5% |
| CPRX | BUY | 2012-07-03 | 2012-07-05 | $0.55 | $11K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2012-05-30 | 2012-05-31 | $0.57 | $10K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2009-11-18 | 2009-11-20 | $0.65 | $6K | -17.6% | -4.9% | -4.9% |
| CPRX | BUY | 2008-11-24 | 2008-11-26 | $1.85 | $6K | -17.6% | -4.9% | -4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.